We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

FDA Authorizes Robotic System for En Bloc Bladder Resection

By HospiMedica International staff writers
Posted on 16 Nov 2026

Bladder cancer frequently recurs, making accurate staging essential for treatment planning. More...

Conventional transurethral resection can fragment tumors, complicating margin assessment and detrusor muscle sampling needed for pathological evaluation. A new system aims to improve specimen quality by enabling removal of bladder lesions in one piece, preserving intact tissue that includes detrusor muscle.

The U.S. Food and Drug Administration (FDA) has granted De Novo authorization for the Virtuoso Endoscopy System, establishing it as the first device in a new classification of electromechanical surgical systems for endoluminal procedures. The system is designed for transurethral en bloc resection of bladder lesions in adult patients to obtain tissue samples, including detrusor muscle, for diagnostic evaluation of bladder cancer. The platform enables removal of many tumors in one piece or larger segments, preserving tissue architecture for pathological review and staging.

The system operates by placing two needle-sized robotic arms at the tip of a rigid endoscope. Constructed from superelastic concentric nitinol tubes, the arms translate the surgeon’s hand motions from a console to lift, retract, and dissect beneath the lesion, providing two-handed dexterity for endoscopic surgery through the urethra. This approach is intended to support intact tissue acquisition and margin evaluation during transurethral procedures.

The FDA authorization establishes a new device classification for robotic instruments passed through an endoscope into the body. The Virtuoso Endoscopy System also received Breakthrough Device Designation in September 2025. Its authorized indications are limited to bladder procedures where a transurethral approach is appropriate, while all other uses remain investigational and are not FDA-authorized.

Clinical evidence from the initial 20 patients in the Virtuoso-sponsored VIABLE (Virtuoso Improving Anatomic Bladder Lesion Excision) study, all treated at The Chinese University of Hong Kong, showed detrusor muscle present in 94% of removed lesions. This exceeded the study’s 60% performance goal and the approximately 70% median rate reported across published studies of conventional transurethral resection of bladder tumors (systematic literature review, data on file). Surgical margins were evaluable in 93% of malignant lesions, and no intraoperative adverse events were reported.

“This is a major milestone for our team and for patients with bladder cancer. Removing a tumor intact can provide a better tissue specimen, which supports clearer diagnosis and staging. We are excited to give surgeons a new tool for this common, recurrent, and potentially deadly cancer,” said Duke Herrell, M.D., urologic surgeon and CEO of Virtuoso Surgical.

“Robotic en bloc resection with Virtuoso changed how we approach these tumors, even for surgeons experienced in the conventional en bloc technique. Surgeons newer to en bloc techniques also obtained high-quality specimens, which could help bring this approach to patients everywhere,” said Professor Jeremy Teoh, principal investigator for VIABLE at The Chinese University of Hong Kong.

Related Links
Virtuoso Surgical


Gold Member
Blood Gas Analyzer
i-Check200
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Digital Radiography System (Ceiling Free)
Digix CF Series
Monitor/Defibrillator
Zenix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image Credit: Shutterstock

AI-Derived Heart Age Linked to Cardiovascular and Dementia-Related Mortality

Cardiovascular disease is increasingly associated with dementia-related mortality and other forms of age-related decline. Identifying people with greater long-term vulnerability before severe outcomes... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image Credit: Adobe Stock

Lung Ultrasound Predicts Progression of Interstitial Lung Abnormalities in Rheumatoid Arthritis

Interstitial lung abnormalities are a pulmonary concern in patients with rheumatoid arthritis, requiring monitoring to detect disease progression. However, tracking these changes often involves repeated... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.